Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Affiliations

• ¹ Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. [email protected].
• ² Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. [email protected].
• ³ Department of Urology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
• ⁴ Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁵ Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁶ Department of Urology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
• ⁷ Department of Radiology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁸ Department of Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
• ⁹ Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.
• ¹⁰ Department of Urology, University of Utah, Salt Lake City, UT, USA.
• ¹¹ Division of Hematology and Medical Oncology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
• ¹² Division of Hematology and Medical Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.
• ¹³ Division of Hematology and Medical Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
• ¹⁴ Genentech, South San Francisco, CA, USA.
• ¹⁵ Formerly with the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁶ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁷ Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁸ Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁹ Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²⁰ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²¹ Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²² Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²³ Gene Dx, Stamford, CT, USA.
• ²⁴ Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ²⁵ Department of Radiation Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²⁶ Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ²⁷ Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.